Stock listing
NASDAQ:MTSR Metsera, Inc. Stock
Follow Metsera, Inc. into a list and get an email when it puts out news.
Last close · NASDAQ:MTSR
$70.50 USD
Close on Nov 13, 2025 · No longer trades
- Lowest – highest close
- $13.08 – $83.18 USDSince Jan 30, 2025 · lowest Apr 10, 2025 · highest Nov 7, 2025
Delisted NASDAQ:MTSR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:MTSR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kristina Burow Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Boundless Bio, Inc. (Director · Since at least Mar 27, 2024); Neumora Therapeutics, Inc. (Director · Since at least Sep 14, 2023); Scholar Rock Holding Corporation (Director · Since at least May 23, 2018); Metacrine Inc (Director · Sep 15, 2020 – May 24, 2021 · Past); Beam Therapeutics Inc. (Director · Feb 5, 2020 – Jun 6, 2023 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 21, 2020 · Past); Gossamer Bio, Inc. (Director · Feb 7, 2019 – Jun 8, 2023 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 24, 2021 · Past); Receptos Inc (Director · Aug 25, 2015 – Aug 25, 2015 · Past) | Director · Since at least Jan 30, 2025 |
| Keith Crandell Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); 908 Devices Inc. (Director · Since at least Dec 17, 2020); Twist Bioscience Corporation (Co-Founder and Managing Director · Since at least Oct 30, 2018); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Quanterix Corporation (Director · Dec 6, 2017 – Apr 3, 2023 · Past); Adesto Technologies Corporation (Director · Oct 26, 2015 – Jun 4, 2019 · Past); Celebrate Express Inc (Director · Oct 19, 2006 – Aug 29, 2008 · Past) | Director · Since at least Nov 13, 2025 |
| Steven Gillis Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); Codiak BioSciences Inc (Director · Oct 13, 2020 – Feb 16, 2023 · Past); VBI Vaccines Inc. (Director · Jun 14, 2019 – Jul 27, 2023 · Past); Q32 Bio Inc. (Director · Jun 6, 2019 – Jun 14, 2023 · Past); Pulmatrix, Inc. (Director · May 16, 2019 – Aug 28, 2020 · Past) | Director · Since at least Nov 13, 2025 |
| Clive Meanwell Other companies: Fractyl Health, Inc. (Executive Chairman and Founder of Population Health Partners · Since at least Feb 1, 2024); Invivyd, Inc. (Director · Jun 22, 2022 – May 23, 2023 · Past); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past); Population Health Investment Co Inc (Chief Executive Officer, Director · Nov 17, 2020 – Aug 24, 2021 · Past); The Medicines Company (Chief Innovation Officer, Director · Jul 1, 2015 – Jan 6, 2020 · Past) | EXECUTIVE CHAIRMAN, Director · Since at least Jan 30, 2025 |
| Paul L. Berns Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); Neumora Therapeutics, Inc. (See Remarks, Director · Since at least Sep 14, 2023); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past); Unity Biotechnology Inc (Director · Jun 24, 2021 – Jun 21, 2024 · Past); Jazz Pharmaceuticals plc (Director · Nov 2, 2020 – Aug 5, 2021 · Past) | Director · Since at least Jan 30, 2025 |
| Matthew Lang Other companies: Structure Therapeutics, Inc. (COO & GC · Since at least Apr 15, 2026); Lyell Immunopharma, Inc. (Chief Business Officer · Jul 1, 2023 – Feb 10, 2025 · Past); Myovant Sciences Ltd (General Counsel & Corp. Secy. · Apr 5, 2019 – Mar 10, 2023 · Past) | CHIEF LEGAL OFFICER · Since at least Apr 28, 2025 |
| Christopher Visioli Other companies: Population Health Investment Co Inc (Chief Financial Officer · Nov 17, 2020 – Nov 17, 2020 · Past); The Medicines Company (Chief Financial Officer · Dec 27, 2019 – Jan 6, 2020 · Past) | CHIEF FINANCIAL OFFICER · Since at least Jan 30, 2025 |
| Jon P Stonehouse Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Dec 14, 2023) | Director · Since at least Apr 28, 2025 |
| Christopher Whitten Bernard | See Remarks, Director · Since at least Jan 30, 2025 |
| Steven Marso | CHIEF MEDICAL OFFICER · Since at least Jan 30, 2025 |
Log in to ask 6ix AI your own questions about Metsera, Inc.